Research Article
FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
Table 1
Basal characteristics of patients with Kawasaki disease (KD) and normal controls.
| ||||||||||||||||||||||||
The number included 13 IVIG-nonresponsive and 22 IVIG-responsive patients and 1 KD patient without record of using IVIG treatment. |